ISLAMABAD, Oct 22 (APP):Federal Minister for National Health Services, Regulations and Coordination Syed Mustafa Kamal on Thursday chaired the first meeting with representatives of three companies to review progress on agreements reached at the Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference 2026. The meeting discussed implementation of the agreements, bilateral cooperation and the future course of action to advance investment and collaboration in the pharmaceutical and healthcare sectors. The participants …
Kamal reviews Pak-China healthcare investment deals
ISLAMABAD, Oct 22 (APP):Federal Minister for National Health Services, Regulations and Coordination Syed Mustafa Kamal on Thursday chaired the first meeting with representatives of three companies to review progress on agreements reached at the Pakistan-China Pharmaceutical and Healthcare B2B Investment Conference 2026.
The meeting discussed implementation of the agreements, bilateral cooperation and the future course of action to advance investment and collaboration in the pharmaceutical and healthcare sectors.
The participants also reviewed the implementation of the medicine track-and-trace system and the introduction of 2D barcodes to strengthen monitoring and transparency in the pharmaceutical supply chain.
During the meeting, it was decided that the Drug Regulatory Authority of Pakistan (DRAP) Management Information System (MIS) team would provide a briefing and practical demonstration of the system.
The meeting also discussed AJ Vaccines’ ongoing visit to Islamabad from October 18 to 22 to explore opportunities for cooperation in local vaccine production and manufacturing.
The initiative reflects Pakistan’s efforts to advance healthcare investment, strengthen pharmaceutical manufacturing capacity and promote cooperation with Chinese and other international partners.
